BeStock  
Stocks › Biotechnology › JAZZ

Jazz Pharmaceuticals JAZZ

US equityMarket cap rank #676Biotechnology
$233.27 +$1.75 (+0.76%)
Market open · Oct 1, 11:50 am ET · After hours $227.76 -1.62%
Open$230.33
Prev close$231.52
Day range$229.93 – $234.06
Volume202.5K
Market cap$15.14B
P/E (TTM)16.0
Dividend yield–

Valuation

Multiples measured against the stock's own five-year history

Price / earnings15.8x
CheapRich

Above its usual level · 63rd percentile, 5-year average 62.9x

#1253 of 2977 stocks by PE (1 = cheapest)

Price / book3.1x
CheapRich

Near the top of its 5-year range · 86th percentile, 5-year average 2.4x

#3712 of 5307 stocks by PB (1 = cheapest)

Price / sales3.3x
CheapRich

Near the top of its 5-year range · 92nd percentile, 5-year average 2.4x

#3248 of 5144 stocks by PS (1 = cheapest)

Morningstar fair value estimate

Fair value$225.00
Price vs. fair value+3.7%Close to the estimate
Star rating★★★☆☆
Economic moatNone
UncertaintyHigh
MultipleCurrentForward5y averagePercentile vs. own historyIndustry rank
PB 3.13 – 2.40 86% (pricier than usual) #3712 of 5307 (1 = cheapest)
PE 15.85 11.80 62.90 63% (pricier than usual) #1253 of 2977 (1 = cheapest)
PS 3.27 3.11 2.39 92% (pricier than usual) #3248 of 5144 (1 = cheapest)

Percentile is against this stock’s own 5-year valuation range: higher means it’s trading rich relative to its own history, lower means cheap relative to its own history — it is not a comparison against other companies. Forward multiples use consensus estimates for the next twelve months; a forward multiple below the current one usually signals analysts expect earnings to grow.

Morningstar view

Star rating★★★
Fair value estimate$225.00
Economic moatNone
UncertaintyHigh

Discussion

No comments yet — be the first to weigh in on JAZZ.

Leave a comment

Scroll to Top